Average Co-Inventor Count = 3.23
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharmaceuticals Corporation (6 from 71 patents)
2. Bayer Healthcare LLC (1 from 779 patents)
3. Bayer Healthcare Aktiengesellschaft (1 from 77 patents)
8 patents:
1. 7494978 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
2. 7488714 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
3. 7488715 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
4. 7488716 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
5. 7399745 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
6. 7378494 - Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide
7. 7041646 - Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
8. 6864069 - Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use